These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3170454)

  • 1. Thioridazine dose effects with reference to stereotypic behavior in mentally retarded residents.
    Aman MG; White AJ
    J Autism Dev Disord; 1988 Sep; 18(3):355-66. PubMed ID: 3170454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of thioridazine and visual screening on stereotypy and social behavior in individuals with mental retardation.
    Singh NN; Landrum TJ; Ellis CR; Donatelli LS
    Res Dev Disabil; 1993; 14(3):163-77. PubMed ID: 8316680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haloperidol treatment with chronically medicated residents: dose effects on clinical behavior and reinforcement contingencies.
    Aman MG; Teehan CJ; White AJ; Turbott SH; Vaithianathan C
    Am J Ment Retard; 1989 Jan; 93(4):452-60. PubMed ID: 2649118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylphenidate in severely retarded residents and the clinical significance of stereotypic behavior.
    Aman MG; Singh NN
    Appl Res Ment Retard; 1982; 3(4):345-58. PubMed ID: 7168571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of thioridazine and withdrawal dyskinesias on workshop performance of mentally retarded young adults.
    Breuning SE; Davis VJ; Matson JL; Ferguson DG
    Am J Psychiatry; 1982 Nov; 139(11):1447-54. PubMed ID: 6753612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-injurious behavior and stereotypy in an institutionalized mentally retarded population.
    Barron JL; Sandman CA
    Appl Res Ment Retard; 1984; 5(4):499-511. PubMed ID: 6524940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose haloperidol for stereotypic self-injurious behavior in the mentally retarded.
    Mikkelsen EJ
    N Engl J Med; 1986 Aug; 315(6):398-9. PubMed ID: 3736616
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of thioridazine dosage on the behavior of severely mentally retarded persons.
    Singh NN; Aman MG
    Am J Ment Defic; 1981 May; 85(6):580-7. PubMed ID: 7023237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of sedative-hypnotic response to self-injurious behavior and stereotypy by mentally retarded clients.
    Barron J; Sandman CA
    Am J Ment Defic; 1983 Sep; 88(2):177-86. PubMed ID: 6638079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case report of naltrexone treatment of self-injury and social withdrawal in autism.
    Walters AS; Barrett RP; Feinstein C; Mercurio A; Hole WT
    J Autism Dev Disord; 1990 Jun; 20(2):169-76. PubMed ID: 2189867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that thioridazine enhances amphetamine-induced stereotypy via anticholinergic activity.
    Robertson A; Campbell C; MacDonald C
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(1):33-40. PubMed ID: 3704172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlorpromazine effects on stereotypic and conditioned behaviour of severely retarded patients--a pilot study.
    Aman MG; White AJ; Field C
    J Ment Defic Res; 1984 Dec; 28 ( Pt 4)():253-60. PubMed ID: 6396416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haloperidol, thioridazine and placebo in mentally subnormal patients-serum levels and clinical effects.
    Väisänen K; Viukari M; Rimón R; Räisänen P
    Acta Psychiatr Scand; 1981 Mar; 63(3):262-71. PubMed ID: 7015792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine treatment of self-injurious behavior in mentally retarded patients.
    Markowitz PI
    J Clin Psychopharmacol; 1990 Aug; 10(4):299-300. PubMed ID: 2286704
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of intermittent drug therapy on stereotypy and collateral behaviors of mentally retarded persons.
    Millichamp CJ; Singh NN
    Res Dev Disabil; 1987; 8(2):213-27. PubMed ID: 2890189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of thioridazine on the intellectual performance of mentally retarded drug responders and nonresponders.
    Breuning SE; Ferguson DG; Davidson NA; Poling AD
    Arch Gen Psychiatry; 1983 Mar; 40(3):309-13. PubMed ID: 6338856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral monitoring of pharmacological interventions for self-injury.
    Singh NN; Winton AS
    Appl Res Ment Retard; 1984; 5(1):161-70. PubMed ID: 6539094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological treatment of self-injurious behavior in mentally retarded persons.
    Singh NN; Millichamp CJ
    J Autism Dev Disord; 1985 Sep; 15(3):257-67. PubMed ID: 2863252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of thioridazine on apomorphine-elicited stereotypic behavior and motor activity.
    Lai H; Carino MA; Sperry R; Horita A
    Pharmacol Biochem Behav; 1980 Sep; 13(3):397-401. PubMed ID: 7191570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic treatments with zotepine, thioridazine, and haloperidol affect apomorphine-elicited stereotypic behavior and striatal 3H-spiroperidol binding sites in the rat.
    Lai H; Carino MA; Horita A
    Psychopharmacology (Berl); 1981; 75(4):388-90. PubMed ID: 6122233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.